生物标志物 生物标志物
Gia Minh Hoang1, Jae Gwan Kim2
1Gwangju Institute of Science and Technology, Bukgu, Gwangju, Korea, Republic of (South).
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
对阿尔茨海默病 (AD) 的早期诊断至关重要. 使用MRI的深度学习模型有效地预测了轻度认知障碍 (MCI) 到AD的进展,显示了高准确性和适时干预的概括性.
科学领域:
- 神经成像和计算神经科学
- 医学中的人工智能
- 神经退行性疾病研究
背景情况:
- 阿尔茨海默氏病 (AD) 诊断需要早期检测才能有效进行干预.
- 轻度认知障碍 (MCI) 是阿尔茨海默病的前期阶段,但由于异质性,预测其进展是具有挑战性的.
- 需要先进的诊断工具来准确识别将发展为AD的MCI个体.
研究的目的:
- 开发一种高度通用的深度学习方法,用于早期诊断MCI进展为AD.
- 使用磁共振成像 (MRI) 预测从MCI转换为AD.
- 提高诊断准确性和普遍性,以区分认知正常 (CN),稳定的MCI (sMCI) 和渐进的MCI (pMCI) 个体.
主要方法:
- 使用多平面特征提取和基于注意力的机制开发了一个深度学习模型.
- 该模型是在阿尔茨海默病神经成像计划 (ADNI) 数据集的MRI数据上进行训练的.
- 在来自广州阿尔茨海默氏症和相关痴呆症 (GARD) 数据库的独立数据集上验证了概括性,比较了CN,MCI,pMCI和sMCI组.
主要成果:
- 该模型在ADNI数据集上实现了CN与MCI的高精度 (91.92%) 和AUC (96.22%),以及pMCI与sMCI的高精度 (78.16%,83.77%).
- 在GARD数据集上,该模型保持了强大的性能,准确度分数为86.25% (CN与MCI) 和76.14% (pMCI与sMCI).
- t-SNE可视化证实了诊断组之间有效的特征分离,表明具有强大的区分能力.
结论:
- 拟议的深度学习框架通过MCI进展预测证明了早期AD诊断的高准确性和通用性.
- 这种方法可以可靠地区分CN和MCI个体,并预测MCI进展到AD.
- 这些发现支持这种神经成像分析工具在早期阿尔茨海默病检测中的临床决策方面的潜力.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516